The diagnosed incident cases of melanoma of the skin in men and woman, ages 18 years and older in the *7MM, are forecast to increase from 165,651 cases in 2016 to 206,717 cases in 2026, at an Annual Growth Rate (AGR) of 2.48% according to GlobalData, a leading data and analytics company.
All markets in this forecast are expected to see an increase in the number of incident melanoma cases, although the US and Australia are anticipated to have significantly higher growth than the **5EU markets.
A spokesperson from the GlobalData Healthcare Analyst team confirmed, “The US is expected to have an AGR of 3.59% followed by Australia having the second highest AGR at 2.03%. The 5EU markets combined have an AGR of 1.12% from 2016-2026.”
Melanoma of the skin is the deadliest form of skin cancer, a global disease affecting all populations around the world but if caught early it can be treated very successfully. The risk of developing melanoma increases significantly in areas of high ultraviolet (UV) exposure and where fair complexions are more common.
* 7MM seven major markets: US, **5EU (France, Germany, Italy, Spain, and the UK) and Japan.